Large-cap Health Care company Cigna has moved -3.8% so far today on a volume of 3,128,418, compared to its average of 1,273,159. In contrast, the S&P 500 index moved 0.0%.
Cigna trades -11.37% away from its average analyst target price of $332.86 per share. The 21 analysts following the stock have set target prices ranging from $287.0 to $385.0, and on average have given Cigna a rating of buy.
Anyone interested in buying CI should be aware of the facts below:
-
Cigna's current price is 1.9% above its Graham number of $289.51, which implies that at its current valuation it does not offer a margin of safety
-
Cigna has moved -9.0% over the last year, and the S&P 500 logged a change of 15.0%
-
Based on its trailing earnings per share of 17.74, Cigna has a trailing 12 month Price to Earnings (P/E) ratio of 16.6 while the S&P 500 average is None
-
CI has a forward P/E ratio of 10.4 based on its forward 12 month price to earnings (EPS) of $28.27 per share
-
The company has a price to earnings growth (PEG) ratio of 1.12 — a number near or below 1 signifying that Cigna is fairly valued compared to its estimated growth potential
-
Its Price to Book (P/B) ratio is 1.89 compared to its sector average of None
-
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States.
-
Based in Bloomfield, the company has 71,300 full time employees and a market cap of $86.33 Billion. Cigna currently returns an annual dividend yield of 1.6%.